The expression level of FTO mRNA was significantly down-regulated in stageII–IV of bladder cancer tissues compared with the normal controls (p = 0.00025 for stageII, p = 0.047 for stageIII and p = 0.0055 for stageIV, Fig. 10). This evidence concerns the gene FTO and urinary bladder carcinoma.